Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey A Meyerhardt, M.D.

Co-Author

This page shows the publications co-authored by Jeffrey Meyerhardt and Paul Lochhead.
Connection Strength

0.927
  1. Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival. Am J Clin Nutr. 2015 Nov; 102(5):1134-41.
    View in: PubMed
    Score: 0.163
  2. Response. J Natl Cancer Inst. 2014 Aug; 106(8).
    View in: PubMed
    Score: 0.151
  3. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst. 2013 Aug 07; 105(15):1151-6.
    View in: PubMed
    Score: 0.140
  4. Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. Eur J Cancer. 2012 Dec; 48(18):3405-13.
    View in: PubMed
    Score: 0.131
  5. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis. J Natl Cancer Inst. 2014 Sep; 106(9).
    View in: PubMed
    Score: 0.038
  6. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features. Ann Surg Oncol. 2014 Dec; 21(13):4164-73.
    View in: PubMed
    Score: 0.037
  7. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014 Jun 05; 33(23):2949-55.
    View in: PubMed
    Score: 0.035
  8. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jun; 22(6):1142-52.
    View in: PubMed
    Score: 0.034
  9. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with ß-catenin (CTNNB1) status. Cancer Res. 2013 Mar 01; 73(5):1600-10.
    View in: PubMed
    Score: 0.034
  10. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013 Apr; 26(4):465-84.
    View in: PubMed
    Score: 0.034
  11. Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst. 2013 Jan 16; 105(2):130-40.
    View in: PubMed
    Score: 0.033
  12. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012 Oct 25; 367(17):1596-606.
    View in: PubMed
    Score: 0.033
  13. Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers. Clin Cancer Res. 2012 Sep 01; 18(17):4753-63.
    View in: PubMed
    Score: 0.033
  14. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review. Clin Cancer Res. 2012 Apr 15; 18(8):2257-68.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.